Strategies targeting the IL-4/IL-13 axes in disease.

Related Articles

Strategies targeting the IL-4/IL-13 axes in disease.

Cytokine. 2015 Aug 5;

Authors: May RD, Fung M

Abstract
IL-4 and IL-13 are pleiotropic Th2 cytokines produced by a wide variety of different cell types and responsible for a broad range of biology and functions. Physiologically, Th2 cytokines are known to mediate host defense against parasites but they can also trigger disease if their activities are dysregulated. In this review we discuss the rationale for targeting the IL-4/IL-13 axes in asthma, atopic dermatitis, allergic rhinitis, COPD, cancer, inflammatory bowel disease, autoimmune disease and fibrotic disease as well as evaluating the associated clinical data derived from blocking IL-4, IL-13 or IL-4 and IL-13 together.

PMID: 26255210 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Targeting CCL28 Protein Structure May Help Prevent Asthma, Study Shows – Lung Disease News


Lung Disease News

Targeting CCL28 Protein Structure May Help Prevent Asthma, Study Shows
Lung Disease News
Asthma is a chronic inflammatory disease of the air passages characterized by airflow obstruction and with common symptoms of wheezing, coughing and shortness of breath. Currently, there is no cure for asthma and affects approximately 25 million people

View full post on asthma – Google News

Scientists report new approach to defeating asthma by targeting allergen – News-Medical.net

Scientists report new approach to defeating asthma by targeting allergen
News-Medical.net
Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists are reporting a new approach to defeating

and more »

View full post on asthma – Google News

Pitt contest awards $100K prizes for projects targeting asthma, diabetes, ACL … – Tribune-Review

Pitt contest awards $100K prizes for projects targeting asthma, diabetes, ACL
Tribune-Review
The contest's grand prize winners included: Nebukin, software that helps children take asthma medication; Nanoketo, a sensor that helps users measure a common problem in diabetes; and ACL Interaction, a way for doctors to tailor treatment for knee

View full post on asthma – Google News

Pitt Innovation Challenge awards $100K prizes for projects targeting asthma … – Tribune-Review

Pitt Innovation Challenge awards $100K prizes for projects targeting asthma
Tribune-Review
The contest's grand prize winners included: Nebukin, software that helps children take asthma medication; Nanoketo, a sensor that helps users measure a common problem in diabetes; and ACL Interaction, a way for doctors to tailor treatment for knee

View full post on asthma – Google News

Targeting asthma, food allergies and more, Allakos bumps up Series A to $42M – San Francisco Business Times (blog)

Targeting asthma, food allergies and more, Allakos bumps up Series A to $42M
San Francisco Business Times (blog)
The San Mateo company, founded by veterans of KaloBios Pharmaceuticals Inc., is developing antibody-based drugs against inflammatory diseases, such as asthma, food allergies and gastrointestinal conditions. It is zeroing in on so-called T-helper cells, …

and more »

View full post on asthma – Google News

Targeting Children’s Asthma Care measures reduced asthma readmission rates – 2 Minute Medicine


2 Minute Medicine

Targeting Children's Asthma Care measures reduced asthma readmission rates
2 Minute Medicine
Quality improvement (QI) initiatives targeting Children's Asthma Care (CAC) measures reduced hospital readmission rates for asthma by 71% at 91 to 180 days post-discharge. 2. Post-discharge follow-up at a patient-centered medical home also increased …
Managing Asthma as a TeamdailyRx
Compliance With Child Asthma Care Measures Cuts ReadmissionDoctors Lounge

all 4 news articles »

View full post on asthma – Google News

Molecular evolution of Peptide ligands with custom-tailored characteristics for targeting of glycostructures.

Related Articles

Molecular evolution of Peptide ligands with custom-tailored characteristics for targeting of glycostructures.

PLoS Comput Biol. 2012 Dec;8(12):e1002800

Authors: Röckendorf N, Borschbach M, Frey A

Abstract
As an advanced approach to identify suitable targeting molecules required for various diagnostic and therapeutic interventions, we developed a procedure to devise peptides with customizable features by an iterative computer-assisted optimization strategy. An evolutionary algorithm was utilized to breed peptides in silico and the “fitness” of peptides was determined in an appropriate laboratory in vitro assay. The influence of different evolutional parameters and mechanisms such as mutation rate, crossover probability, gaussian variation and fitness value scaling on the course of this artificial evolutional process was investigated. As a proof of concept peptidic ligands for a model target molecule, the cell surface glycolipid ganglioside G(M1), were identified. Consensus sequences describing local fitness optima were reached from diverse sets of L- and proteolytically stable D lead peptides. Ten rounds of evolutional optimization encompassing a total of just 4400 peptides lead to an increase in affinity of the peptides towards fluorescently labeled ganglioside G(M1) by a factor of 100 for L- and 400 for D-peptides.

PMID: 23271960 [PubMed – in process]

View full post on pubmed: asthma